Tag:

drug prices

Latest Headlines

Latest Headlines

Report: U.S. specialty-med spending on the rise

The age of the specialty drug is upon us. Spending on traditional meds may still be on the rise, but it's the complex treatments for multiple sclerosis, cancer, inflammatory conditions and other

Early hep C drug pricing spooks experts

New hepatitis C treatments from Merck and Johnson & Johnson are selling in France for $31,000 and up, and their price tags may end up limiting access to the high-tech drugs, especially in

Will KV's 55% Makena price cut satisfy critics?

Answering a firestorm of criticism--as well as an unusual move by FDA--KV Pharmaceutical took an axe to the $1,500 price on its new prenatal drug Makena, cutting it back by 55 percent. The treatment,

Religious groups target rising drug prices

Patient groups, politicians, government agencies--these are the usual sources of complaints about rising drug prices. But now, some religious organizations are pushing Big Pharma to reconsider the

Calif. official: Lower AIDS drug prices

California State Controller John Chiang is pushing forward aggressively with a campaign to get drugmakers to lower the price of the AIDS medication Atripla, according to a report by Ed Silverman on

Supreme Court: County can't sue for alleged drug overcharging

The U.S. Supreme Court has ruled that only the federal government has a right to enforce its rules against overcharging for prescription drugs in public-health facilities and that the parties

Gout medicine Colcrys' pricing under scrutiny

Slate wades in on recent drug-pricing news, and accompanying outrage among some in the media and in Congress, with an update on the gout medicine colchicine. Like February's news involving KV

Chinese government slashes drug prices by 21%

China may be a new frontier for Big Pharma, but like the Old West, this land of opportunity has its dangers. Witness the government's latest pricing move, which will cut the maximum retail prices on

Jurors debate in GSK-Abbott drug-pricing dispute

The scrap over Abbott Laboratories' HIV-drug pricing has gone to a jury. In federal court in Oakland, CA, GlaxoSmithKline and Abbott have been trading arguments about a price hike on Norvir, an AIDS

KV blinks, but Makena pricing tactic common

Feeling the pushback from patients, doctors and Congress over the aggressive pricing of the recently approved Makena--a hormone injection used to prevent premature births--KV Pharma says in an SEC